given
potenti
laboratoryassoci
sever
acut
respiratori
syndromeassoci
coronaviru
sarscov
infect
must
know
cell
line
suscept
viru
investig
cell
line
routin
use
viru
isol
research
infect
sarscov
cell
observ
cytopath
effect
quantit
realtim
polymeras
chain
reaction
use
measur
ongo
viral
replic
indirect
immunofluoresc
assay
also
use
confirmatori
test
studi
identifi
new
cell
line
capabl
support
replic
sarscov
confirm
suscept
cell
line
previous
report
studi
show
sarscov
isol
sever
cell
line
commonli
use
diagnost
research
purpos
also
show
sarscov
achiev
high
titer
sever
cell
line
sometim
absenc
specif
cytopath
effect
ever
acut
respiratori
syndrom
sar
first
observ
case
lifethreaten
atyp
pneumonia
occur
guangdong
provinc
china
novel
coronaviru
cov
design
sarscov
quickli
identifi
etiolog
agent
although
origin
viru
establish
evid
suggest
anim
viru
recent
transmit
human
sever
wildlif
speci
consum
delicaci
southern
china
includ
himalayan
mask
palm
civet
chines
ferret
badger
raccoon
dog
possess
antibodi
consist
natur
infect
relat
cov
unlik
current
recogn
human
cov
usual
caus
mild
upper
respiratori
tract
infect
occasion
pneumonia
older
adult
neonat
immunocompromis
patient
sarscov
caus
sever
febril
lower
respiratori
tract
ill
lead
pneumonia
acut
respiratori
distress
death
progress
respiratori
failur
due
alveolar
damag
occur
patient
symptomat
infect
current
world
free
sar
predict
whether
viru
reemerg
probabl
sourc
futur
infect
exposur
anim
reservoir
laboratori
sarscov
manipul
research
purpos
inde
sinc
first
epidem
sar
occur
occas
result
breach
laboratori
biosafeti
procedur
find
highlight
import
safe
handl
sarscov
especi
diagnost
virolog
laboratori
viru
isol
perform
research
laboratori
infecti
viru
handl
sarscov
first
isol
vero
frhk
cell
inject
clinic
specimen
part
earli
attempt
identifi
etiolog
agent
sar
simultan
investig
show
sarscov
could
replic
number
cell
line
routin
use
respiratori
viru
isol
recent
addit
human
anim
cell
line
support
sarscov
replic
identifi
given
potenti
sarscov
infect
occur
laboratori
set
must
awar
cell
line
replic
therefor
investig
suscept
number
cell
line
sarscov
cell
deriv
varieti
speci
tissu
includ
capabl
support
replic
respiratori
enter
virus
isol
sarscov
strain
hku
passag
occas
vero
cell
establish
hightit
stock
use
infect
experi
sarscov
classifi
risk
group
level
pathogen
australia
procedur
perform
viru
includ
infect
cell
line
viral
lysi
rna
extract
carri
physic
contain
level
laboratori
cell
line
investig
suscept
sarscov
shown
tabl
chosen
present
cell
repositori
use
either
routin
occasion
viru
isol
attempt
part
diagnost
research
project
confluent
cell
maintain
flask
nunc
roskild
denmark
contain
ml
appropri
mainten
medium
supplement
fetal
bovin
serum
fb
thermo
trace
melbourn
victoria
australia
uml
penicillin
streptomycin
jrh
bioscienc
lenexa
ks
usa
bgm
frhk
hel
hep
pcmk
rda
cell
line
maintain
modifi
eagl
medium
mem
supplement
fb
mdck
cell
maintain
mem
supplement
fb
helat
cell
maintain
basal
medium
eagl
supplement
fb
co
vero
vero
cell
line
maintain
dulbecco
modifi
eagl
medium
dmem
supplement
fb
mek
cell
maintain
medium
fb
cell
maintain
rpmi
medium
supplement
fb
confluent
cell
infect
sarscov
result
multipl
infect
result
shown
mockinfect
medium
addit
flask
also
prepar
origin
inoculum
incub
experiment
condit
within
cellfre
environ
day
infect
cell
observ
sarscovspecif
cytopath
effect
cpe
supernat
collect
viru
detect
quantif
polymeras
chain
reaction
pcr
mainten
medium
replac
cell
test
virusspecif
antigen
indirect
immunofluoresc
assay
day
infect
sarscov
cpe
observ
cpe
develop
involv
least
cell
monolay
eleven
day
infect
cell
line
neg
indic
viral
replic
blindpassag
twice
day
ad
cultur
supernat
cell
question
well
highli
suscept
vero
cell
passag
cell
observ
sarscovspecif
cpe
second
passag
supernat
collect
viru
detect
quantif
pcr
volum
lysi
buffer
contain
guanidinium
thiocyan
triton
roch
diagnost
mannheim
germani
ad
supernat
cell
cultur
either
infect
sarscov
mockinfect
sampl
remov
laboratori
laboratori
underw
nucleic
acid
extract
magna
pure
lc
total
nucleic
acid
isol
kit
magna
pure
lc
autom
extract
robot
roch
diagnost
volum
eluat
treat
min
ad
ml
revers
transcript
master
mix
contain
uml
random
hexam
roch
diagnost
deoxynucleosid
triphosph
roch
diagnost
u
amvrt
enzym
promega
madison
wi
usa
incub
min
min
cdna
product
store
analyz
pcr
realtim
pcr
amplifi
fragment
nucleoprotein
gene
use
detect
quantifi
sarscov
refer
cycl
threshold
ct
assay
use
prism
instrument
appli
biosystem
foster
citi
ca
usa
primer
probe
design
associ
primer
express
softwar
forward
primer
sarnpf
aga
tgg
tac
ttc
tat
tac
cta
revers
primer
sarnpr
tac
gat
gcc
ttc
ttt
gtt
probe
sarnpp
ctt
cac
ttc
cct
acg
mgb
realtim
pcr
templat
cdna
ad
abi
taqman
univers
pcr
master
mix
appli
biosystem
contain
primer
probe
total
volum
ml
cycl
condit
follow
min
min
cycl
min
refer
standard
curv
shown
demonstr
neg
chang
ct
valu
repres
increas
viru
titer
log
cell
collect
day
infect
cpe
observ
microscopi
day
develop
cpe
involv
least
cell
monolay
cell
manual
scrape
monolay
ml
cultur
medium
subject
kgi
gamma
radiat
spot
onto
slide
air
dri
fix
aceton
min
earlier
test
show
dose
gamma
radiat
reduc
titer
sarscov
least
tissu
cultur
infecti
dose
result
shown
volum
dilut
convalescentphas
serum
sarscovinfect
patient
ad
fix
cell
follow
incub
min
humidifi
chamber
slide
wash
twice
phosphatebuff
salin
pb
dri
cell
spot
overlaid
antihuman
fluorescein
isothiocyanateconjug
secondari
antibodi
durham
nc
usa
min
slide
wash
twice
pb
mount
cover
slip
virusspecif
immunofluoresc
read
use
axioskop
uv
microscop
zeiss
oberkochen
germani
final
result
indirect
immunofluoresc
assay
shown
tabl
base
observ
independ
reader
suscept
sarscov
cell
line
investig
shown
tabl
result
obtain
line
indic
test
first
time
previous
report
other
cell
line
test
previous
confirm
previou
data
show
could
support
replic
line
test
first
time
shown
support
replic
sarscov
gener
cell
deriv
nonhuman
primat
kidney
suscept
human
liver
cell
line
hep
rabbit
kidney
cell
also
support
replic
sarscov
replic
bgm
frhk
pcmk
vero
cell
line
produc
cpe
earli
day
inocul
evid
high
level
virusspecif
rna
establish
quantit
pcr
cpe
focal
cell
round
refract
soon
follow
cell
detach
cpe
quickli
spread
involv
entir
cell
monolay
figur
contrast
neither
mek
co
cell
produc
sarscovspecif
cpe
figur
despit
evid
rapid
mek
limit
co
replic
determin
quantit
pcr
figur
indirect
immunofluoresc
test
shown
cell
line
capabl
support
sarscov
replic
immunofluoresc
result
confirm
quantit
pcr
result
case
tabl
figur
show
quantit
pcr
result
repres
cell
line
day
isol
attempt
result
depict
ct
valu
rel
ct
valu
cellfre
prepar
cellfre
prepar
initi
ct
valu
obtain
origin
inoculum
seed
flask
contain
ml
dmem
input
ct
increas
ct
valu
day
infect
supernat
bgm
mek
vero
vero
cell
line
yield
ct
valu
unit
lower
initi
cellfre
inoculum
day
infect
number
equat
titer
increas
log
ml
input
viru
cell
result
helat
mdck
cell
repres
cell
line
support
sarscov
replic
shown
figur
cell
line
ct
valu
day
infect
level
similar
cellfre
inoculum
later
time
success
media
chang
ct
valu
increas
manner
similar
cellfre
control
prepar
indic
dilut
input
viru
absenc
subsequ
viral
replic
blind
passag
supernat
fluid
cell
line
confirm
result
shown
contrast
ct
valu
co
cell
chang
cours
experi
suggest
viral
replic
occur
low
level
suffici
maintain
similar
viral
titer
input
level
sever
medium
chang
sar
epidem
end
sever
case
occur
direct
indirect
result
breach
laboratori
biosafeti
breach
highlight
need
safe
handl
viru
laboratori
includ
know
cell
line
may
suscept
infect
studi
add
list
cell
known
support
replic
sarscov
approach
establish
suscept
infect
use
quantit
pcr
support
immunofluoresc
test
quantit
pcr
use
distinguish
ongo
viral
product
input
viru
group
use
altern
strategi
investig
sarscov
replic
includ
use
pcr
capabl
amplifi
subgenom
rna
molecul
produc
replic
result
show
laboratori
reversetranscript
pcr
avail
appropri
reagent
avail
immunofluoresc
test
simpl
rapid
method
assess
whether
cell
expos
respiratori
enter
specimen
infect
viru
basi
studi
earlier
report
monkey
kidney
cell
line
particularli
suscept
sarscov
infect
african
green
cynomolgu
rhesu
monkey
kidney
cell
line
previous
shown
suscept
identifi
first
time
kidney
cell
deriv
fourth
nonhuman
primat
speci
buffalo
green
monkey
product
infect
sarscov
titer
reach
log
ml
input
viru
similar
level
monkey
kidney
cell
found
monkey
kidneyderiv
cell
line
includ
ing
bgm
frhk
pcmk
vero
support
replic
sarscov
titer
log
ml
input
viru
titer
high
titer
sarscov
attain
cell
line
consid
use
viru
isol
purpos
appropri
safeti
guidelin
follow
abil
sarscov
replic
effici
kidneyderiv
cell
line
surpris
given
function
receptor
metalloproteas
angiotensinconvert
enzym
highli
express
kidney
tissu
metalloproteas
receptor
wide
diverg
aminopeptidas
n
receptor
group
cov
express
lung
heart
kidney
gastrointestin
tissu
consist
patholog
sar
gener
close
agreement
seen
result
previous
report
although
differ
seen
cpe
show
pcmk
cell
support
develop
sarscovspecif
cpe
wherea
cpe
observ
cell
line
earlier
studi
although
replic
occur
studi
cell
observ
cpe
day
infect
wherea
present
studi
observ
cell
day
pcmk
cell
line
observ
cpe
often
develop
slowli
affect
popul
cell
progress
figur
neither
co
mek
cell
develop
sarscovspecif
cpe
figur
despit
evid
replic
pcr
immunofluoresc
co
cell
deriv
african
green
monkey
kidney
fibroblast
cell
line
highli
suscept
sarscov
reason
decreas
level
viru
product
relat
co
cell
remain
determin
may
due
lower
level
surfac
express
receptor
nevertheless
result
cell
line
highlight
unreli
cpe
measur
sarscov
replic
given
primat
kidneyderiv
cell
line
particularli
suscept
infect
sarscov
viru
isol
kidney
infect
human
patient
suspect
human
kidneyderiv
cell
line
might
also
support
sarscov
replic
howev
studi
gillimross
et
al
human
cell
line
shown
product
infect
sarscov
found
agreement
studi
cell
suscept
infect
viru
addit
identifi
third
human
cell
line
hep
deriv
hepatocellular
carcinoma
also
suscept
infect
although
produc
lower
level
virusspecif
rna
cell
hep
cell
line
use
research
laboratori
studi
hepat
b
c
virus
suggest
cell
line
use
research
purpos
need
consid
care
potenti
support
sarscov
replic
guidelin
must
establish
prevent
simultan
work
multipl
differ
virus
within
laboratori
studi
shown
sarscov
isol
sever
cell
line
commonli
use
diagnost
research
purpos
highlight
viru
achiev
high
titer
cell
line
sometim
absenc
cpe
find
particularli
relev
laboratori
scientist
undertak
virusisol
procedur
specimen
collect
patient
atyp
respiratori
diseas
research
laboratori
possibl
simultan
handl
viru
exist
